CHARLES RIVER LABORATORIES
CRL · NYSE
Updated at 2026-10-14 08:17:34
- Today's High
- $302.77
- Today’s Low
- $295.15
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $301.80
- Previous Close
- $301.86
- Volume
- 543.77K
- Market Cap
- $14.41B
- P/E Ratio
- --
- EPS
- $-4.85
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Life Sciences Tools & Services
- Sub-industry
- DIAGNOSTICS & RESEARCH
- Headquarters
- 251 BALLARDVALE STREET, WILMINGTON, MA, UNITED STATES, 01887
- Country
- US
- Listing Date
- 2000-06-23
- Fiscal Year End
- December
- Shares Outstanding
- 48.17M
- CIK
- 0001100682
- Website
- www.criver.com
Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the Pharmaceutical, Medical device and Biotechnology industries. It also supplies assorted biomedical products and outsourcing services for research and development in the pharmaceutical industry and offer support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.
Financial Metrics
Revenue
2026-06-30
$1B
2026-03-31
$995.83M
2025-12-31
$994.22M
2025-09-30
$1B
Operating Expenses
2026-06-30
$243.48M
2026-03-31
$159.42M
2025-12-31
$187.63M
2025-09-30
$204.99M
Net Income
2026-06-30
-$1.48M
2026-03-31
-$14.84M
2025-12-31
-$276.55M
2025-09-30
$54.42M
Net Profit Margin
2026-06-30
-0.14%
2026-03-31
-1.49%
2025-12-31
-27.81%
2025-09-30
5.41%
Earnings Per Share
2026-06-30
$3.02
2026-03-31
$2.06
2025-12-31
$2.39
2025-09-30
$2.43
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$150.8M
2026-03-31
$63.95M
2025-12-31
-$192.04M
2025-09-30
$197.76M
Effective Tax Rate
2026-06-30
101.42%
2026-03-31
50.56%
2025-12-31
6.05%
2025-09-30
36.28%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $1B | $995.83M | $994.22M | $1B |
| Operating Expenses | $243.48M | $159.42M | $187.63M | $204.99M |
| Net Income | -$1.48M | -$14.84M | -$276.55M | $54.42M |
| Net Profit Margin | -0.14% | -1.49% | -27.81% | 5.41% |
| Earnings Per Share | $3.02 | $2.06 | $2.39 | $2.43 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $150.8M | $63.95M | -$192.04M | $197.76M |
| Effective Tax Rate | 101.42% | 50.56% | 6.05% | 36.28% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.